mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.005 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.006 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.006 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.006 |